Tart cherry for crohn's relief
Part of Digestive system clinical trials.
This trial tests if drinking tart cherry juice can help reduce symptoms of Crohn's disease. It's for people with mild to moderate Crohn's who are on a stable medication routine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn's disease for at least 6 months.
- Your Crohn's is currently mild to moderate in severity.
- You are between 18 and 65 years old.
- You have been taking the same Crohn's medications for at least 3 months.
- You do not have diabetes, HIV, hepatitis B or C.
- You have no food allergies to cherries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a daily cranberry supplement can improve gut health and quality of life in people with Crohn's disease. It may help those whose current treatment is stable but still have bothersome symptoms.
This study tests a medicine called tirzepatide to see if it can help people with active Crohn’s disease who have not responded to multiple prior treatments. It focuses on how the drug might work beyond just reducing inflammation.
This trial tests an experimental drug called R-3750 for people with active Crohn's disease. It aims to see if the drug can reduce inflammation and improve symptoms.
This study tests whether a specially designed anti-inflammatory American diet can help control mild to moderate Crohn's Disease symptoms. Participants will follow a diet plan, with guidance from the research team, to see if it reduces inflammation and improves quality of life.
This trial tests an experimental drug for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The drug aims to reduce inflammation and may help improve symptoms.
This study tests an experimental drug called SAR442970 for people with moderate to severe Crohn's disease who haven't had success with standard treatments or biologics. The goal is to see if it can reduce inflammation and improve symptoms.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.